Equities

C-Mer Eye Care Holdings Ltd

C-Mer Eye Care Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)2.98
  • Today's Change0.00 / 0.00%
  • Shares traded180.00k
  • 1 Year change-26.24%
  • Beta0.7667
Data delayed at least 15 minutes, as of May 28 2024 04:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

C-Mer Eye Care Holdings Ltd is an investment holding company mainly engaged in the provision of health care services. The Company is engaged in the provision of ophthalmic services; sales of vision aid products including glasses and lens; provision of other medical services including dental, oncology, medical aesthetics, and laboratory services; sales of pharmaceutical products.

  • Revenue in HKD (TTM)1.92bn
  • Net income in HKD62.00m
  • Incorporated2016
  • Employees3.27k
  • Location
    C-Mer Eye Care Holdings LtdSuite 1515, Central Building1-3 Pedder Street, Central Hong KongHKG
  • Phone+852 39973266
  • Fax+852 39968212
  • Websitehttps://cmereye.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
3309:HKG since
announced
Transaction
value
Apollo Lens Co LtdAnnounced01 Jun 202301 Jun 2023Announced-22.60%7.10m
Data delayed at least 15 minutes, as of May 28 2024 04:31 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rici Healthcare Holdings Ltd3.23bn392.32m1.89bn9.41k4.821.562.800.58640.24670.24672.030.76420.650345.8010.35342,855.808.733.2416.255.7841.7537.0013.435.930.64715.640.67050.0026.0116.8556.06--2.51--
Town Health International Medical Gp Ltd1.83bn-194.21m1.93bn1.40k--0.5954--1.05-0.0287-0.02870.27060.47870.396324.255.041,310,249.00-3.44-1.21-4.29-1.4427.3829.06-8.68-4.013.161.340.1121--19.3710.32-1,370.26---25.95-13.65
EC Healthcare4.10bn-3.74m1.96bn2.72k--1.043.110.4766-0.0032-0.00323.471.590.76156.2316.481,591,122.000.43157.500.681513.4184.7187.530.566610.240.81441.080.389393.0632.7424.27-64.73-24.2551.5214.87
Mega Genomics Ltd163.16m32.39m2.19bn229.0064.192.8145.0713.450.14440.14440.75163.300.201415.921.01712,494.404.00--4.60--58.36--19.85--5.80--0.07--3.82--270.50------
Chaoju Eye Care Holdings Ltd1.48bn246.86m2.65bn2.60k10.591.017.151.800.35410.35412.123.700.485114.4626.75568,682.307.828.088.809.5645.3543.8116.1215.474.9025.560.077951.5738.3316.7021.9242.68-2.33--
Arrail Group Ltd1.71bn-136.24m3.60bn3.46k--1.9425.362.10-0.234-0.2343.303.200.496923.7317.73502,446.50-3.98---5.33--17.80---8.00--2.14-16.700.3657---9.23--68.63------
C-Mer Eye Care Holdings Ltd1.92bn62.00m3.75bn3.27k60.542.0212.231.950.04940.04941.531.480.68128.9338.29587,828.903.060.92373.871.1232.1729.954.491.441.7516.840.15445.3311.0934.98383.427.8128.01--
China Resources Medical Holdings Com Ltd10.90bn277.88m5.41bn20.17k18.970.86275.340.49610.21980.21988.624.830.642324.506.63540,347.102.083.243.494.8018.8620.293.246.600.600523.910.247927.9527.9237.46-3.07-9.7753.23-10.65
Data as of May 28 2024. Currency figures normalised to C-Mer Eye Care Holdings Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

2.96%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 09 May 202415.71m1.25%
BlackRock Fund Advisorsas of 09 May 20245.93m0.47%
Dimensional Fund Advisors LPas of 09 May 20245.65m0.45%
Bosera Asset Management Co., Ltd.as of 31 Dec 20224.34m0.35%
Norges Bank Investment Managementas of 31 Dec 20233.00m0.24%
Charles Schwab Investment Management, Inc.as of 09 May 2024822.47k0.07%
TIAA-CREF Investment Management LLCas of 31 Mar 2024500.00k0.04%
Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024412.47k0.03%
SSgA Funds Management, Inc.as of 09 May 2024394.00k0.03%
Legal & General Investment Management Ltd.as of 28 Mar 2024354.00k0.03%
More ▼
Data from 31 Dec 2023 - 22 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.